Previous studies have shown that expression of the heparan sulfate proteoglycan, perlecan, on the external trophectodermal cell surfaces of mouse blastocysts increases during acquisition of attachment competence. However, it is not clear if this change in perlecan protein expression also is reflected at the level of perlecan mRNA expression. In the present investigation, the spatial and temporal patterns of perlecan mRNA expression in the mouse embryo during the periimplantation period were examined by in situ hybridization and reverse transcriptase-polymerase chain reaction. In addition, a delayed implantation model was used to determine the expression of perlecan mRNA and protein in dormant and estrogen-activated hatched blastocysts. The results demonstrate that perlecan mRNA expression is low in morulae, but increases in Day 4 blastocysts, attaining maximal expression in Day 4.5 attachment-competent blastocysts. In contrast, perlecan mRNA is detected in both the dormant and estrogen-activated delayed blastocysts; however, within 12 hr of blastocyst activation by estrogen, both perlecan protein and heparan sulfate chain expression markedly increase. Taken together, these results suggest that during normal development perlecan mRNA expression increases with the acquisition of attachment competence. Moreover, perlecan protein expression also is attenuated during delayed implantation and appears to increase in response to nidatory estrogen, perhaps via the increased translation of preexisting perlecan mRNA. ᭧ 1997 Academic Press
INTRODUCTION
or the presence of soluble HS competitors all delayed blastocyst attachment to a variety of matrices including laminin, fibronectin, and uterine epithelial cells (Farach et al., 1987 , Successful implantation is dependent upon an intimate 1988 . It has also been demonstrated that mouse and human ''cross-talk'' between the embryo and the uterus. Once the uterine epithelial cells express complementary HS binding blastocyst hatches from the zona pellucida, its trophectoproteins that may aid in blastocyst attachment (Wilson et derm becomes attachment competent, i.e., gains the ability al Raboudi et al., 1992; Liu et al., 1996 ; Rohde et to attach to the uterine luminal epithelium. At the same al., 1996) . Recently, the HSPG, perlecan, has been identified time, the uterus must be in a ''receptive'' state for successful at the sites of blastocyst apposition in the uterus in vivo implantation to occur. The attainment of the receptive state (Carson et al., 1993) . Perlecan is a 400-kDa protein comof the uterus is primarily regulated by ovarian estrogen and monly found in the basal lamina underlying epithelial cells. progesterone (Psychoyos, 1986) . A role for heparin/heparan
Of the five domains in perlecan, the amino terminus is sulfate proteoglycans (HSPGs) in mouse embryo attachment unique, including attachment sites for HS chains. In addihas been suggested (see review Carson et al., 1994) . Synthetion, there is no transmembrane domain (Noonan, et al., sis of HSPGs increases on the murine embryonic cell surface 1991). Since perlecan expression on the cell surface of blasduring the periimplantation period (Farach et al., 1987) . Intocysts increases during acquisition of attachment compehibition of embryonic proteoglycan synthesis, specific retence, it is possible that this proteoglycan is one of the moval of heparan sulfate (HS) from blastocyst cell surfaces, HSPG mediators of trophectoderm -luminal epithelial cell attachment. However, it is not clear if the perlecan gene is expressed coordinately with the increase in perlecan protein 1 To whom correspondence should be addressed.
Slides were examined under a dissecting scope for the presence of under these conditions. In order to expand on previous studembryos, allowed to air dry, and held on dry ice until all the emies, in situ hybridization was used to determine the spatial bryos had been processed. Slides containing embryos were stored and temporal expression of perlecan mRNA in periimplan- (Yoshinaga and Adams, 1966;  these conditions. Using an experimentally delayed implan- Paria et al., 1992 
MATERIALS AND METHODS
horn was flushed and the other uterine horn was snap frozen in a dry ice/isopentane bath and stored at 080ЊC until sectioned. To Materials. CF-1 mice were obtained from Sasco (Omaha, NE).
establish whether embryos were hatched, 7-mm sections of uteri Tissue-Tek O.C.T. was purchased from Miles Inc. (Elkhart, IN) .
containing blastocysts were probed with antibodies to zona pelluRabbit antibody to human basic fibroblast growth factor (bFGF) cida (ZP) proteins 2 and 3 and tenascin as previously described was purchased from Collaborative Research, Inc. (Bedford, MA). (Julian et al., 1994) . Detection of ZP2/ZP3 indicated that the blastoSpecies-specific fluorescein-conjugated rhodamine-conjugated seccyst was still encapsulated by the ZP and unhatched. The absence ond antibodies to rabbit and rat IgG were obtained from Amersham of ZP2/ZP3 and the presence of tenascin, an extracellular matrix Corporation (Arlington Heights, IL). Rat anti-heparan sulfate proprotein induced in subepithelial stroma, were used as markers for teoglycan (perlecan) monoclonal antibody was purchased from hatched, attachment-competent blastocysts (Julian et al., 1994 (Wilmington, DE) . RNase A, restriction performed as previously described (Carson et al., 1993) . In the presenzymes, and yeast RNA were purchased from Boehringer-Mannent study, a rat anti-perlecan monoclonal antibody was used. In heim Biochemicals (Indianapolis, IN). Ultrapure phenol was puragreement with earlier results, using the rabbit polyclonal antichased from Gibco BRL (Gaithersburg, MD) and formamide from body, the rat monoclonal antibody recognized perlecan in sections Fluka (Ronkonkoma, NY). All other reagents used in this study from Day 4.5 implantation sites in the basal lamina, in extracellular were of reagent grade or better. matrix surrounding uterine stroma, and between uterine epitheEmbryo collection. Female mice were injected intraperitonelium and trophectoderm of hatched blastocysts (data not shown). ally with 5 IU of pregnant mare serum gonadotropin and 48 hr later These experiments were performed on at least 10 different implanwith 5 IU of human chorionic gonadotropin (hCG). Following hCG tation sites. For double labeling of cytospun embryos with both injection females were caged with males of proven fertility. FebFGF and anti-perlecan, embryos were fixed 10 min in 100% methmales were examined the following morning for the presence of a anol and incubated with bFGF for 2 hr at 37ЊC. Upon application vaginal plug indicating Day 1 of pregnancy. It has been shown in of the anti-bFGF, the anti-perlecan also was added. Embryos were previous studies (Carson et al., 1993) that uteri collected from mice processed as mentioned previously. FITC donkey anti-rabbit and in our colony at 96 hr post-hCG injection and flushed with Hanks' RITC donkey anti-rat secondary antibodies were applied together. balanced salt solution contain approximately 80% unhatched blasRiboprobe preparation. Linearized DNA clone (clone 5 in tocysts. However, approximately 80% of the blastocysts are Noonan et al., 1988) for mouse perlecan in Bluescript (SK
) vector hatched when recovered 108 hr post-hCG injection. Using the go-(Stratagene) was used. Approximately 1 mg of linearized template nadotropin injection regimen described above, embryos were DNA was used to generate sense and antisense riboprobes. The flushed from the reproductive tract during three developmental total reactivity incorporated into 35 S-labeled cRNA probes obtained time periods. Embryos were collected at 76 hr (Day 3 morula, unusing 1 mg of DNA as template along with RNA polymerase T3 or hatched), 96 hr (Day 4 blastocysts, unhatched), and 108 hr (Day T7 was usually 0.3-1.4 1 10 8 dpm. The probes were purified by 4.5 blastocysts, hatched) post-hCG injection. Zona pellucidae were phenol:chloroform extraction and ethanol precipitation. To enremoved from unhatched embryos with acid Tyrode's solution hance probe penetration into the tissue, the pelleted probes were (Gordon, 1993) .
hydrolyzed to approximately 100 nucleotides in the presence of 60 Cytospin collection of embryos. Ten to twelve embryos from mM Na 2 CO 3 and 40 mM NaHCO 3 , pH 10.2, as described by Cox the time points stated above were transferred into a cytospin funnel et al. (1984) . Riboprobes were recovered by ethanol precipitation preloaded with 200 ml of Hanks' balanced salt solution and centriand resuspended in 10 mM Tris -HCl (pH 7.5), 1 mM EDTA, and 10 mM dithiothreitol and stored at 070ЊC until use. fuged for 5 min at 2000 rpm in a Shandon Elliott tabletop centrifuge.
In situ hybridization. Frozen serial sections of implantation 100 ml with the addition of 70 ml of 11 PCR buffer and 2.5 mM MgCl 2 and overlayered with 100 ml of mineral oil. Following a 1-sites and isolated embryos as described above were subjected to in min incubation at 95ЊC, 35 repeated cycles were carried out with situ hybridization using protocols described previously (De et al., 30 sec at 95ЊC, 30 sec at 55ЊC, and 30 sec at 72ЊC followed by a 1989; McMaster et al., 1992) . Briefly, slides were removed from the 10-min final extension at 72ЊC. The PCR products were ethanol-070ЊC freezer, warmed to 37ЊC for 1 min, and fixed in 4% (w/v) precipitated, resuspended in tracking dye gel buffer, and loaded on paraformaldehyde in PBS for 15 min. Following prehybridization, a 5% nondenaturing polyacrylamide gel in 0.51 Tris -borate EDTA 150 ml of hybridization solution containing 2 1 10 7 cpm/ml was buffer. The gel was dried and exposed to X-ray film. The bands added to each sample and covered with a silconized coverslip. Hywere quantified by scanning with a laser densitometer. bridization was carried out at 45ЊC for 4 hr. Unhybridized probe was digested with 20 mg/ml of RNase A at 37ЊC for 15 min. Hybridized probe was detected after 2 weeks of autoradiography using Kodak NTB-2 emulsion. Following development, slides were RESULTS poststained with hematoxylin and eosin. At least 20 embryos at each developmental stage have been examined in these studies.
Isolation of total RNA. Total RNA was isolated from Day 4
Analysis of perlecan mRNA in mouse embryos by in situ and Day 4.5 mouse blastocysts as described by Andrews et al. (1991) hybridization and RT -PCR during normal pregnancy.
with the following modifications: Blastocysts (80-100 per group)
Previous in vivo and in vitro studies have demonstrated were collected as described above, quick frozen on dry ice, and that perlecan protein is present on the exterior surface of stored at 070ЊC. Embryos were allowed to thaw on ice and resusthe trophectoderm during the attachment phase of implanpended in SDS buffer, phenol saturated with SDS buffer, and 20 mg tation (Carson et al., 1993 trifugation, the organic layer was carefully removed and discarded.
In uterine sections obtained from Day 4 pregnant mice, by Wegner et al. (1995) . RNA from 80 blastocysts was reverse tranestablishing the specificity of the antisense probe (Fig. 1A) . In situ hybridization using the sense probe does not show localization to a specific region. Perlecan mRNA localization detected by the antisense probe is abundant in the stromal cells (s) subjacent to the uterine epithelium surrounding the embryo (e).
mural and polar trophectoderm. These data indicate that closely accompanied acquisition of attachment competence during normal embryonic development. perlecan mRNA expression increased closely following or coincident with the process of hatching. To quantitate the Perlecan protein and mRNA expression in blastocysts during delayed implantation. Given the results obtained increase in perlecan mRNA expression between unhatched stage blastocysts and hatched blastocysts, the number of during normal pregnancy, it was of interest to determine the consequences of implantation delay on perlecan mRNA silver grains per embryo was counted for morulae, unhatched blastocysts, and hatched blastocysts, for both sense and protein expression. In this model, embryos hatch from the zona pellucida, but do not become attachment compeand antisense probes. The mean number of grains/embryo, shown in Fig. 3A , indicates a significant difference between tent until a nidatory dose of estrogen is administered. Expression of several other blastocyst genes is associated with the hatched blastocyst stage embryo and all groups, with P õ 0.0001. The relative increase in antisense probe hybridthis activation event (Paria et al., 1992 (Paria et al., , 1993a . Immunohistochemical staining techniques were used to detect perization between unhatched (Day 4.0) and hatched (Day 4.5) blastocysts was approximately sixfold. Similar results were lecan core protein and HS chain expression. Specificity controls included use of nonimmune ascites fluid versus ascites obtained using an RT -PCR assay. RNA encoding a constitutively expressed ribosomal protein, L19, was used as an fluid containing rat monoclonal IgG directed at perlecan (compare Fig. 4 , panels A and B) and predigestion of embryos internal control as described previously (Wegner et al., 1996) . As shown in Fig. 3B , a marked (sevenfold) increase with heparinases to remove HS chains (Fig. 4 , panels C and D) or competition with excess heparin (Fig. 6 , panels B and was observed for perlecan mRNA relative to L19 transcript between Day 4.0 (unhatched) and Day 4.5 (hatched, attach-D) for the HS detection technique. While it is possible that bFGF might bind to components other than HS, the efficient ment-competent) blastocysts. These results indicated that, like perlecan protein, increased perlecan mRNA expression competition with heparin and inhibition of bFGF binding by heparinase predigestion strongly suggest HS is the pretion. In contrast to protein expression, in situ hybridization analysis demonstrated that the transcript for perlecan was dominant bFGF ligand detected in these experiments.
Increased levels of perlecan protein were detected in blaspresent in both dormant (Fig. 7B ) and estrogen-activated (Fig. 7D) blastocysts. As observed with normal blastocysts, tocysts at 12 hr (Fig. 5B ) and 24 hr (Fig. 5C ) after estradiol activation compared to dormant embryos maintained on the transcript appeared to be present in the inner cell mass as well as the mural trophectoderm. Again, an absence of progesterone alone (Fig. 5A) . In addition to the perlecan core protein, HS expression, as detected by bFGF staining (Siedlocalized signal observed with a sense probe demonstrated the specificity of the antisense perlecan probe (Fig. 7F) . lak et al., 1991), was elevated following estradiol activation, with a similar temporal pattern (Fig. 6) . Thus, both perlecan These data, together with those obtained with normally implanting embryos, indicate that elevated expression of core protein and HS polysaccharide expression were elevated in dormant blastocysts in response to estrogen activaperlecan mRNA does not require estrogen activation. In 
DISCUSSION
In the present study, we have established that perlecan mRNA is initially detected in unhatched Day 4 blastocysts. After hatching from the zona pellucida, the blastocysts become attachment competent and perlecan mRNA is abundantly expressed. This correlates with perlecan protein expression displayed on the trophectodermal surface of Day 4.5 blastocysts, but absent in Day 4 unhatched blastocysts (Carson et al., 1993) . Previous studies have detected extracellular matrix components in early preimplantation embryos prior to the formation of a basement membrane (see review by Leivo, 1983) . These components include collagen IV, laminin, HSPG molecules, and nidogen (Leivo et al., 1980; Sherman et al., 1980; Wu et al., 1983; . After blastocyst formation, discontinuous patches of collagen type IV and fibronectin are exhibited on the inner aspects of the mural trophectoderm (Leivo et al., 1980; Wartiovaara et al., 1979) . It is possible that these proteins expressed on the inner trophectodermal lining aid in the migration of parietal endoderm cells which deposit Reichert's membrane. Consistent with this view, we noted accumulation of perlecan mRNA in the inner cell mass region. In addition to deposition in the blastocyst interior, perlecan is present on the outer surface of trophectoderm cells at the time of attachment competence (Carson et al., 1993) . The presence of this HSPG on the outer surface of trophectoderm cells suggests a possible role for perlecan in embryo -uterine attachment.
In normal developing blastocysts, both perlecan protein (Carson et al., 1993) and mRNA increase markedly during the transition from unhatched to hatched, attachment competent blastocysts. During delayed implantation in vivo, blastocysts hatch, but do not attach providing an additional test of potential HSPG function in the implantation process. It was of interest to determine if perlecan mRNA and protein were present in dormant blastocysts or induced in dormant blastocysts activated by estrogen (Huet-Hudson and Dey 1990; Paria et al., 1992) . Under these conditions, we detected perlecan protein in blastocysts 12 hr post-estrogen injection, with maximal expression at 24 hr. Since HS sults from the present study indicate that both perlecan dormant embryos, as shown in A; however, little definition of cell peripheries was evident in these embryos and this pattern of staincore protein and HS expression are elevated in delayed blasing was similar to that observed with nonimmune rat IgG. In contocysts in response to estrogen. While it is possible that trast, cell peripheries were evident in B and C, and the overall bFGF might bind to other ligands, e.g., FGF receptors, the intensity of staining was markedly increased. Perlecan protein exheparinase digestion control (Fig. 4D) suggests that the mapression increased within 12 hr of estrogen activation (B) and perjority of bFGF is binding to HS chains, located on the amino sisted through 24 hr (C). Original magnification, 4301.
terminus of the Pln core protein, or one of the HS chains must interact with cell surface proteins. This would allow the remaining HS chains to interact with bFGF. There is contrast, enhanced expression of perlecan core protein, as also a possibility that the Pln core protein could be decorwell as HS chains, requires additional developmental events ated with chondrotin sulfate (CS) chains or with no glycosaminoglycan chains at all (Couchman et al., 1996) . Comthat can be triggered by estrogen stimulation.
FIG. 6.
Heparan sulfate (HS) chain expression increases in response to activation of dormant blastocysts. bFGF staining was used to detect HS chain expression in cytospun, dormant, or estrogen-activated blastocysts, as described under Materials and Methods. The figure shows staining of delayed embryos (A) and estradiol-activated (B and D, 12 hr; C, 24 hr) embryos incubated with bFGF in the absence (A, B, C) or the presence (D) of 1 mg/ml heparin. Note the increased staining of the activated embryos at 12 (B) and 24 (C) hr post-estrogen injection. This staining is markedly reduced by inclusion of heparin during the bFGF staining step (D). The staining observed in A and D is comparable to that observed if bFGF was omitted from the staining procedures. Original magnification, 4301. pared to HS, relatively little CS is synthesized at this stage slower rate of perlecan mRNA degradation in the dormant blastocyst. This is in contrast to the finding of a rapid disapof development (Farach et al., 1987) . Furthermore, given the coordinate increase in expression of perlecan mRNA and pearance of EGF receptor mRNA in the blastocyst coinciding with the initiation of delayed implantation (Paria et al., protein with the HS chains on the blastocyst surface, it seems likely that, in this instance, Pln is decorated with 1993a). The expression of an HSPG molecule on the surface of HS chains.
In contrast, perlecan mRNA was expressed in blastocysts attachment-competent blastocysts at the time of implantation suggests a role for this molecule in implantation. At maintained in delay and was, therefore, present prior to estrogen activation and protein expression. Following actithe time embryos become attachment competent, the uterus must also be in a state of receptivity for implantation vation, perlecan mRNA was still present in the inner cell mass and trophectoderm of activated blastocysts. Since perto occur (Psychoyos, 1986; Paria et al., 1993b) . Interactions between the trophectoderm and uterine luminal epithelial lecan mRNA is present prior to nidatory estrogen and perlecan protein expression increases after nidatory estrogen, cells are critical for attachment in all species (Enders and Schlafke, 1974) . Recently, the heparin binding EGF-like it appears that perlecan may be subject to translational regulation. However, it is not clear whether the accumulation growth factor (HB-EGF) gene was found to be locally induced in mouse uterine luminal epithelial cells at the sites of perlecan mRNA was due to continued transcription or a HS chains of perlecan, promoting attachment and stimulate embryonic development. Description of HSPG expression in mouse embryos may provide a model to determine the precise role of these molecules in the implantation process.
